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Abstract—Phase-change contrast agents in the form of nanoscale droplets can be activated into microbubbles by 
ultrasound, extending the contrast beyond the vasculature. This article describes simultaneous optical and acoustical 
measurements for quantifying the ultrasound activation of phase-change contrast agents over a range of concentrations. 
In experiments, decafluorobutane-based nanodroplets of different dilutions were sonicated with a high-pressure 
activation pulse and two low-pressure interrogation pulses immediately before and after the activation pulse. The 
differences between the pre- and post-interrogation signals were calculated to quantify the acoustic power scattered by 
the microbubbles activated over a range of droplet concentrations. Optical observation occurred simultaneously with 
the acoustic measurement, and the pre- and post-microscopy images were processed to generate an independent 
quantitative indicator of the activated microbubble concentration. Both optical and acoustic measurements revealed 
linear relationships to the droplet concentration at a low concentration range <10
8
/mL when measured at body 
temperature. Further increases in droplet concentration resulted in saturation of the acoustic interrogation signal. 
Compared with body temperature, room temperature was found to produce much fewer and larger bubbles after 
ultrasound droplet activation. (E-mail:  Mengxing.tang@imperial.ac.uk)  
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The use of microbubbles as a contrast agent for medical 
ultrasound has enabled a range of applications in 
medicine (Cosgrove 2006). The routinely adopted 
diagnostic applications include using microbubbles as a 
blood pool marker for endocardial border delineation 
(Elhendy  et al. 2004; Kaufmann et al. 2007) and liver 
vasculature imaging (Cosgrove 2007; Oldenburg et al. 
2005; Vilana  et al. 2006). Many other diagnostic 
applications also look promising, such as contrast-
enhanced ultrasound imaging of the spleen (Harvey et 
al. 2005) and kidney (Cosgrove and Chan 2008; Quaia 
et al. 2003), as well as detection of neovascularization 
and atherosclerotic plaques (Coli et al. 2008; Feinstein 
2006) in the 
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coronary and carotid arteries. Recent studies also 
promoted the use of microbubbles for quantitative 
(Sboros and Tang 2010; Tang et al. 2011; Wei et al.  
1998), targeted and molecular imaging (Klibanov  
2007). In addition to the aforementioned diagnostic 
applications, microbubbles are also considered for use as 
gene and drug delivery vehicles (Lentacker et al. 2006; 
Unger  et al. 1998) and thermal ablation enhancers 
(Coussios  et al. 2007; Stride and Coussios 2010) for 
ultrasound therapy.  
Limitations of microbubble-mediated ultrasound 
techniques include the rapid dispersion and clearance of 
microbubbles in vivo and the incapability of interrogating 
or delivering drugs within the interstitial space of solid 
tumours because of the enhanced permeability and 
retention effect (Hobbs et al. 1998). To extend their use in 
the extra-vascular space, there have been studies on phase-
change contrast agents (PCCAs) since 1995 (Albrecht et al. 





the vaporization of nanoscale droplets into microbubbles 
by ultrasound (termed acoustic droplet vaporization) 
after their permeation through blood vessels, for 
example, into the interstitial space of tumours. During 
the past two decades, there have been many studies on 
the application of nanodroplets in vascular imaging 
(Correas et al. 2001; Kasprzak and Ten Cate 1998), 
molecular recognition for cancer detection (Lin and Pitt  
2013; Sheeran et al. 2013b), drug delivery (Rapoport  
2012; Rapoport et al. 2011) and enhanced tumour 
ablation (Zhang and Porter 2010; Zhang et al. 2011). In 
addition, droplets have been found to have unique 
applications, which microbubbles may not, in ultrasound 
aberration correction (Haworth et al. 2008), vascular 
occlusion (Samuel et al. 2012; Zhang et al.  2010) and 
contrast-enhanced photo-acoustic imaging (Strohm et al. 
2012; Wilson et al. 2012).  
In 2011, a new decafluorobutane-based PCCA was 
developed that has been found to be not only more uniform 
and smaller (peak size: 200–300 nm), but also stable. It was 
also found to be sufficiently labile to vaporization by a 
clinical ultrasound pulse at body temperature (Sheeran et 
al. 2011). High-speed microscopic images illustrated that 
once the droplets were vaporized, the particle usually 
expanded approximately five times in diameter, with the 
exception of some large outliers that resulted from bubble 
fusion, a secondary effect of the ultrasound vaporization 
pulse, and/or a secondary effect of the pressurization 
procedure in droplet preparation (Lin  and Pitt 2013; 
Sheeran et al. 2011, 2013a). The same studies also 
indicated that, with a stronger ultrasound activation pulse, 
the microbubbles produced tended to shift to a smaller-
sized population, and although the ultra-sound pressure 
needed for droplet activation increased with ultrasound 
frequency, the mechanical index, which is more relevant to 
clinical implementation, decreased with ultrasound 
frequency (Sheeran et al. 2011, 2013a).  
Some fundamental research on acoustic 
characterization of the ultrasound activation of droplets has 
been reported. For example, the degree of inertial cavitation 
during acoustic droplet vaporization was previously studied 
(Fabiilli et al. 2009; Giesecke and Hynynen 2003). 
Evidence from cavitation detection suggested that the phase 
transition usually occurred before the existence of inertial 
cavitation. The acoustic signature of the acoustic droplet 
vaporization was reported in Sheeran  et al. (2014). The 
acoustic signal produced by single-droplet vaporization was 
found to be distinct from the typical microbubble and tissue 
scattered echo signal. Results also indicated that monitoring 
growth of the newly generated microbubbles may allow 
differentiation of converted droplets from the surrounding 
stable microbubbles by tracing the change in scattered 
sound power at fundamental and harmonic frequencies 
(Reznik et al. 2011). 
 
 
Furthermore, uniform activation of nanodroplets was 
achieved in vivo, and a 16- to 20-dB increase in contrast 
was characterized by comparing the linear intensity of 
two ultrasound images pre- and post-droplet activation 
in a rat kidney (Puett et al. 2014). Although the relation-
ship between microbubble concentration and scattered 
acoustic power was described previously (Lampaskis  
and Averkiou 2010), the relationship between droplet 
concentration and bubble concentration after 
vaporization has not been studied previously and needs 
to be investigated because of the additional complexity 
and un-certainty of the droplet–bubble conversion. In 
this study, we establish the relationships between droplet 
concentration and simultaneous optical and acoustic 
measurements acquired pre- and post-droplet activation 




Droplet preparation  
Phase-change contrast agents were produced using the 
‘‘microbubble condensation’’ method described by Sheeran 
et al. (2011). Briefly, lipid-coated, decafluorobutane-filled 
microbubbles were first produced in 2-mL sealed vials 
according to the formulation and procedure described 
(Sheeran et al. 2011). Microbubbles (gaseous state) were 
condensed to nanodroplets (liquid core) by gently swirling 
the vials in a 27°C bath while pressurizing 40 mL room air 
into vials through a syringe connected to a 25G needle. In  
Figure 1 are microscopic images of the microbubble 
emulsion before and after condensation at the top and 
bottom planes of the hemocytometer. Both samples were 
diluted to 1:20 and allowed to stand for 5 min before the 
images were acquired to allow for stratification, if it did 
occur. Figure 1(a, c) illustrates that before condensation, 
microbubbles were observed only at the top plane because 
of their buoyancy. Immediately after condensation, a 
majority of the microbubbles disappeared from the top 
plane (Fig. 1b). The remaining large microbubbles in  
Figure 1b were most likely a result of a small number of 
large outlier droplets that were relatively easily vaporized 
even without an ultrasound activation pulse. This could be 
due to the smaller Laplace pressures on the larger droplets. 
Droplets, being comprised of dense liquid decafluorobutane 
(1.517 g/mL), settled to the bottom of the hemocytometer 
(indicated by the arrows in  Fig. 1d). By subtracting the 
micro-bubble concentration measured after condensation 
(~5×107 bubbles/mL) from that measured before 
condensation (~6×109 bubbles/mL) using the protocol 
described in Sennoga et al. (2010), the concentration of the 
droplet emulsion was estimated to be on the order of 
~5.5×109 droplets/mL. The microbubbles that remained in 



























Fig. 1. Microscopic images focused at the top and bottom planes of the cytometer containing microbubbles only (a, c) 
and droplets with few spontaneously activated bubbles (b, d). Bar = 20 µm. 
 
 
experiments as this would account for the spontaneous 
vaporization of droplets, which could occur in vivo. 
 
Acoustic measurement  
The experimental setup is illustrated in Figure 2. 
Droplets of various concentrations (1%–30%) were 
injected through a 200-µm-inner-diameter transparent 
and sonolucent microcellulose tube. The tube was then 
immersed in a 37°C water tank and equilibrated 
 
 
to achieve the physiologic temperature. A 10-MHz 
single-element focused ultrasound transducer (focal 
length = 40 mm, f-number = 2.01, Panametrics, MA, 
USA) transmitted a pulse train containing a high-
pressure ‘‘activation pulse’’ to vaporize the 
nanodroplets and two low-pressure ‘‘interrogation 
pulses’’ before and after the activation pulse to quantify 
the acoustically activated droplets. The pulse train was 





















































Fig. 3. Procedure for optical quantification of acoustic droplet activation (a–d). Bar = 20 µm. 
 
tube. The activation pulse consisted of 10 cycles at 10 
MHz with a negative peak pressure of 6.0 MPa 
(mechanical index [MI] = 1.9). The interrogation pulses 
were stimulated 33.3 µs before and after the activation 
pulse and consisted of two cycles at 5 MHz with a 
negative peak pressure of 0.044 MPa (MI = 0.02). The 
scattered sound field of the pulse train was received by 
another spherically focused ultrasound transducer (focal 
length = 49.7 mm, f-number = 1.96, Panametrics, MA, 
USA) with a resonant frequency of 5 MHz. The 
receiving transducer, transmission transducer and 
microscope were angled (~120°) relative to each other to 
minimize reception of the activation pulse-echo that is 
reflected from the microscope lens and the water–air 
interface. For each of the received pulse-echo signals, a 
2-µs rectangular window was used to temporally isolate 
the echo signals scattered only from the contents within 
the microcellulose tube. The foci of the receiving 
transducer (850 µm in lateral, 8.75 mm in axial) fully 
covers the foci of the transmitting transducer (450 µm in 
lateral, 6.25 mm in axial) so that the entire region 
through which the sound was scattered by the activated 
droplets could be detected. Transmission and detection 
were synchronized, and the acoustic signal detected was 
bandpass filtered (100 kHz–35 MHz) and amplified (20 
dB) before acquisition. For each concentration, 10 repeat 
measurements were made to produce statistics, and each 
repeated measurement was made using a fresh set of 
droplets. 
 
Acoustic signal processing  
The power spectral densities (PSDs) of two 
interrogation pulse echoes were calculated and then 
integrated over the spectrum to characterize the scattered 
acoustic power. The difference between the scattered 
acoustic powers was used to quantify the droplets that were 
activated by the vaporization pulse. The mean and standard 
deviation of the 10 repeat measurements were calculated. 
 
Optical observation  
As a confirmation of the acoustic measurement, a 
water immersion objective lens (Olympus LUMPlanFl, 
M = 100×, NA = 1.0) focused light at the same position 
as the acoustic foci, through which slow motion videos 
(120 fps, 0.46 µm per pixel) were recorded on a home-
use complementary metal oxide semiconductor (CMOS) 
camera (Canon IXUS 220 HS) simultaneously with the 
acoustic measurement to visualize acoustic droplet 
vaporization. Each video took about 3 s, long enough to 
cover the entire period of the ultrasound pulse train, 
including both acoustic droplet activation and acoustic 
interrogation. 
 
Optical image processing  
To quantify acoustic droplet vaporization, frames 
directly before and after droplet vaporization (Fig. 3a, b) 
were selected from the video and then subtracted to leave 
only the newly generated bubble (activated droplet) image 
(Fig. 3c). The generated bubbles had positive values in the 






















Fig. 4. Microscopic images (a–f) and corresponding interrogation echo signals (g–l) acquired before and after the 
‘‘activation pulse’’ in droplets and controls. Bar = 20 µm. 
 
with positive values corresponded to the generated bubbles 
because of motion artefacts from the microcellulose tube 
secondary to water movement. To avoid motion artefacts, a 
threshold (intensity >0.1) was set for the normalized 
subtracted image to produce a binary microbubble image. 
Pixels with a value of one in Figure 3d were counted to 
estimate the cross-sectional area of the generated 
microbubbles. The cross-sectional area is used to 
approximate the concentration of the newly generated 
bubbles, to cross-validate the acoustic measurement. At 
low concentrations, it can be assumed that the scattered 
acoustic power is linear with the concentration of micro-
bubbles (Lampaskis and Averkiou 2010). 
 
Controls  
In addition to acoustic droplet activation 
measurement, the same arrangement described above 
was used except the droplet emulsion was replaced by 
(i) water only and (ii) microbubbles (diluted to 1:80) in 
the micro-cellulose tube as controls. The water control 
and water bath were purified and placed a day before 
use to equilibrate the gas with atmospheric pressure 




Optical and acoustic measurements  
In  Figure 4 are the optical images and corresponding 
acoustic interrogation echo signals acquired before and 
after the ultrasound ‘‘activation pulse’’ in water, micro-
bubble and droplet emulsions, respectively. For water, no 
changes were observed both optically and acoustically. 
Because of the high-pressure activation pulse (6-MPa 
negative peak pressure at 10 MHz) some micro-bubbles 
were destroyed (Fig. 4d) and many droplets were 
 
vaporized (Fig. 4f, the black clouds), in agreement with the 
optical observation. For microbubbles, the amplitude of the 
post-activation interrogation pulse echo (after the activation 
pulse) was lower than that of the pre-activation 
interrogation pulse echo (before the activation pulse) 
secondary to microbubble destruction (Fig. 4i, j). For 
droplets, the post-interrogation pulse echo had a higher 
amplitude than the pre-interrogation pulse echo because of 
the increased scattering of sound of the newly formed 
microbubbles (Fig. 4k, l). All measurements indicated that 
the 33-µs intervals between the interrogation, activation 
and interrogation pulses were long enough to temporally 
resolve the individual pulse echo signals received by the 
detection transducer.  
Figure 5 illustrates the power spectrum density of 





















Fig. 5. Power spectral density (PSD) of the ‘‘difference 
















Fig. 6. (a–d) Microscopic images of variously diluted droplet emulsions acquired after droplet vaporization. Bar = 20 
µm. (e) Optical quantification as an indicator of the concentration of generated bubbles. Data at relative concentrations 
>0.04 (stars) were not included in the linear fitting. 
 
defined as the difference between the post- and pre-
interrogation pulse echoes. The shadows indicate the 
standard deviation of the 10 repetitive measurements. 
Consistent with the results illustrated in  Figure 4, the 
difference signal has a negative value for microbubble 
emulsion as a result of bubble destruction and a positive 
value for droplet emulsion as a result of droplet activation. 
 
Quantification of droplet activation  
In Figure 6 are microscopic images of the various 
dilutions of droplet emulsions acquired immediately after 
launching the activation pulse and their corresponding 
optical measurements. The dilution was characterised by 
the ‘‘relative droplet concentration’’ (relative 
concentrations of 0, 1%, 1.5% and 2% are illustrated as an 
example in Fig. 6a–d), where ‘0’ indicates a measurement 
in water. The y-axis in Figure 6e represents the number of 
pixels (n) of activated droplets in the subtracted binary 
image (e.g., as illustrated in Fig. 3d), which indicates the 
concentration of generated bubbles and was normalized to 
the result of the most diluted droplets (1%) in the 
measurement. The results indicate that more droplets were 
vaporized with increasing droplet concentration, and the 
concentration of the generated microbubbles 
 
correlated linearly with the relative droplet concentration. 
The solid line represents the linear regression of the 
experimental data (relative concentrations 0–4%) with a R
2
 
of 0.994, indicating good confidence in the linear 
relationship. The relative concentrations >4% (stars) were 
not included in the linear fitting.  
Figure 7 illustrates the acoustic measurements of 
droplet activation. Similar to Figure 5, the PSD of the 
acoustic interrogation difference signal is plotted in  Figure 
7a for various dilutions of droplets (relative concentrations 
of 0–2% are illustrated as an example). The y-axis 
represents the acoustic scattered power normalized to the 
result of the most diluted droplets (1%). Figure 7a 
illustrates that the PSD of the difference signal increased 
with relative droplet concentration as a result of the 
elevated droplet activation and acoustic scattering. To 
quantify droplet activation acoustically, the power of the 
difference signal scattered by the newly generated bubbles 
was calculated by integrating the PSD over the spectrum 
(Fig. 7b). The power was again normalized to the 1% 
diluted droplet emulsion. As the inset in Figure 7b 
suggests, the power of the difference signal responds 
linearly to droplet concentrations <2%. With further 
















Fig. 7. Acoustic measurement of droplet vaporization: (a) power spectral density and (b) power of the interrogation 
‘‘difference signal.’’ Data at relative concentrations 0–2% (diamond markers) were used in the linear fitting, as 




















Fig. 8. Microscopic images of the acoustically vaporized droplets at different temperatures. (a) Undiluted droplets 
activated at 21°C. (b) Droplets diluted to 1:3 and activated at 37°C. Bar = 20 µm. 
 
optical measurement continues to increase linearly (up 
to 4%), the acoustic signal begins to saturate at relative 




In this study, the acoustic vaporization of 
sequentially diluted droplets was quantified 
simultaneously using optical and acoustical 
measurements. 
 
Optical measurements  
To date most optical studies have focused on the 
observation of individual bubbles after droplet 
vaporization to determine such parameters as the size of 
the microbubbles generated and the threshold of droplet 
activation as a function of various parameters of the 
acoustic activation pulse (Lin and Pitt 2013; Sheeran  et 
al. 2011, 2013a). Some studies have also looked into the 
droplet vaporization process, for example, observation 
of the over-expansion during vaporization and the 
sequential unforced radial oscillation after vaporization 
for individual perfluorocarbon microdroplets using a 
high-speed camera (Sheeran et al. 2014). This work 
looking at vaporization of individual droplets provided 
 
an useful understanding of the phase conversion pro-cess. 
In the present study, the optical measurements made 
simultaneously with acoustic measurements not only were 
used for cross-validation of ‘‘on/off’’ droplet activation as 
in previous studies (Sheeran et al. 2014), but also were 
analysed further to generate a quantitative indicator of the 
volume of the generated microbubbles as a function of 
droplet concentration (i.e., the entire ensemble of 
nanodroplets). The microscopic images were acquired 
immediately before and after acoustic droplet activation 
and the pre- and post-images were subtracted and 
thresholded to extract the pixels corresponding to the 
generated microbubbles (converted droplets). Assuming the 
individual microbubbles are in focus and not overlapping in 
the optical images, the total dark pixel number n can be 
related to the cross-sectional area of the generated bubbles 
in the slice observed by microscopy. If we assume the 
bubble concentration in the slice is proportional to the 
bubble concentration in the vessel, n could be used as an 
indicator of the concentration of the generated 
microbubbles within the acoustic focus. The optical 
measurement indicated a linear relationship with droplet 
concentration for well-diluted droplets (<4%) ( Fig. 6e), but 
















Fig. 9. (a) Acoustic and (b) optical quantification of droplet activation at 21°C. Both measurements (50 repetitions) 
were normalized to the results measured using the droplets with a relative concentration of 0.2 (20%).
  
 
droplets (e.g.,>4%). One possible explanation is that 
because of the out-of-plane effect in the microscopy 
images, factors such as the clustering or coalescence of 
the generated bubbles (most likely to occur with high 
concentrations) could result in underestimation of the 
bubble volume (e.g., for relative concentrations >4% in  
Fig. 6e). It should be noted that although it is assumed 
that the accumulated cross-sectional area (dark pixel 
number) can be used to estimate the concentration of the 
generated microbubbles, the exact relationship between 
this area measure and the number of bubbles is more 
complex, largely because the analysis is based on 
accumulated area measurement rather than on individual 
bubbles. Further studies are required. 
 
Acoustic measurement  
In the acoustic measurement, the difference between 
the two interrogation pulses pre- and post-vaporization was 
determined to quantify droplet activation. The method of 
comparing pre- and post-droplet activation was reported 
previously in  Puett et al. (2014) where a customised pulse 
sequence similar to what was used in this work was also 
used to form two bubble images pre- and post-vaporization 
to characterize the increase in contrast increase via droplet 
activation. As per previously cited work (Reznik et al. 
2011; Schad and Hynynen 2010), the power in fundamental 
and/or harmonic bands was traced for consecutive 
interrogation pulses after droplet activation to study the 
growth of the generated bubbles and the threshold of 
inertial cavitation. In our work, the pre- and post-
interrogation echo powers were subtracted in fundamental 
frequency to quantify the acoustic power scattered from the 
newly generated microbubbles as a function of droplet 
concentration. We used the fundamental frequency instead 
of harmonics primarily because the interrogation signal at 
the fundamental frequency was much higher than the 
harmonics. Because the measurement has a natural control 
signal (pre-vaporization), the tissue background can be 
subtracted, leaving only the signal sensitive to newly 
generated bubbles. The acoustic quantification results 
indicated a linear relationship with droplet concentration 
for well-diluted droplets (<2%); however, with further 
increase in droplet concentration, the acoustic measurement 
saturated. The plateau in Figure 7b may be caused by the 
non-linearity of acoustic scattering through microbubbles. 
On the one hand, a greater number of generated 
microbubbles could deflect more sound into the focus area 
of the detector, potentially increasing the scattered acoustic 
power; on the other hand, a greater number of activated 
droplets could in-crease the attenuation of the acoustic 
energy and, there-fore, possibly decrease the acoustic 
power received. The counter-effect was most likely 
responsible for the saturation of the acoustic signal for the 
highly activated 
 
droplet emulsion. The acoustic measurements in this 
study can be expanded to imaging in diagnostic and 
therapeutic applications involving the use of 
nanodroplets. Harmonics detection (Puett et al. 2014; 
Reznik et al.  2011) may be added in the future to 
provide more information on droplet activation, for 
example, characterization of the size distribution of the 
generated microbubbles. 
 
Temperature dependence  
Previous studies have indicated a dependence on 
temperature for acoustic droplet activation. It has been 
found that the efficiency of droplet activation increases 
with temperature and droplet size. The same trend was 
observed in our optical results, as illustrated in  Figure 8, 
where the measurements conducted at room temperature 
(21°C) are compared with the measurements conducted 
at body temperature (37°C). Figure 9 illustrates the 
acoustic and optical quantification measurements 
conducted at 21°C. The linear relationship was again 
observed; however, the linearity appeared to be 
expanded to the entire range of droplet concentrations as 
a result of the reduced droplet activation efficacy at 
21°C. One may also note that the standard deviation in  
Figure 9 is much larger. A possible reason is that fewer 
droplets were vaporized, and most of these were large 
outlier droplets (Fig. 9).  Figures 6e, 7b and 9 together 
illustrate a temperature dependence of linearity in both 
acoustic and optical measurements. 
 
Concentration measurement  
The effect of droplet concentration has been dis-
cussed in some previous work to some degree, for example, 
for determining the threshold of droplet vaporization 
(Reznik et al. 2011) and for evaluating the chance of 
successful detection of the low-frequency acoustic sig-
natures produced by the droplet phase conversion (Sheeran 
et al. 2014). As an extension of current under-standing, this 
work added new results on establishing direct quantitative 
links between droplet concentration, volume of generated 
microbubbles and acoustic power scattered from the 
generated bubbles. Once the experimental system is 
calibrated, the method may be used for the rapid and 
quantitative measurement of nanodroplet concentration in 
vitro. Considering the microbubble concentration used to 
generate sufficient contrast in images in clinical use (~105 
bubbles/mL), the droplets used in this study (~5.5×109 
droplets/mL) may be diluted to 1% in practice, assuming 
10% of the exposed droplets can be vaporized by the 
activation pulse (Reznik et al. 2013). It is also useful to 
note that as the droplet activation efficiency may be 
reduced in vivo (Puett et al. 2014), for example, because of 
the attenuation effect, the linear range described in this 
article may 
  
shift toward the high concentrations for in vivo 
applications. This will be studied in the future, as will 
the linear relationship for acoustic droplet activation in 




Simultaneous acoustic and optical measurements of 
the pre- and post-activation of perfluorocarbon-based 
nanodroplets indicated a linear relationship with droplet 
concentrations for well-diluted droplets. The subtracted 
acoustic power became saturated at droplet 
concentrations greater than ~108 droplets/mL at body 
temperature. Compared with body temperature, room 
temperature was found to produce much fewer and 
larger bubbles after ultrasound droplet activation. 
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